Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Choosing Appropriate Covid-19 Prevention Strategies
Charles Vega, MD, FAAFP; Stefan Gravenstein, MD, MPH; Elie Saade, MD, MPH
So Cal 2026 Postgame: Live Cases and Conversations™: Improving Identification and Management of Patients with Tardive Dyskinesia
Gustavo Alva, MD; Carey Martin, PMHNP, FNP, DNP
So Cal 2026 Postgame: Integrating Glutamatergic Agents to Advance Care for Patients with MDD
Jason Kellogg, MD; Gustavo Alva, MD
Show Me Your Care Plan™: Navigating Biomarkers to Guide and Support NSCLC Care
Benjamin P. Levy, MD; Laura Alder, MD; Beth Sandy, MSN, CRNP, FAPO
Community Practice Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2– Breast Cancer
Virginia Kaklamani, MD, DSc; Komal Jhaveri, MD, FACP
SimulatED: Integrating Precision Pathways in HER2+ Gastroesophageal Adenocarcinoma — Testing, Treatment, and Supportive Care
Geoffrey Y. Ku, MD; Sunnie S. Kim, MD
Burst CME Part II: Current and Emerging Treatment Options for Managing Edema in CKD and HF
Stephen Greene, MD
Burst CME Part III: Managing Fluid Overload to Reduce Patient Burden in CKD and HF
Amir Kazory, MD, FASN, FAHA
Burst CME Part I: Reducing Fluid Overload in Early-Stage CKD and HF
Katherine DiPalo, PharmD, MBA, MS
Project ECHO®: Applying PD-L1 Testing in mTNBC: Making Sense of Biomarker-Driven Frontline Care
Tiffany A. Traina, MD, FASCO; Nour Abuhadra, MD; Francesca Gany, MD, MS; Hannah Y. Wen, MD, PhD
Une Vision d’Espoir: Lighting the Way in GA Management & Treatment
SriniVas R. Sadda, MD, FARVO; Hong-Uyen Hua, MD; Adrienne W. Scott, MD, FASRS
SoCAL 2026: Integrating Motivational Interviewing Techniques to Overcome Barriers to the Use of a Long-Acting Injectable Agent in Patients With Schizophrenia
Gerald Maguire, MD; Jacob Hanaie, PharmD, APh, BCPP; Charles Nguyen, MD, DFAPA
SoCAL 2026: PER Regional Psychiatry Series: Optimizing Treatment for Difficult-to-Treat Depression: The Role of Vagal Nerve Stimulation Therapy
Gus Alva, MD, DFAPA; Lara Shirikjian, DO
Expert Illustrations & Commentaries™: The Science of Extended Durability
Talia Kaden, MD; Diana Do, MD
BURST CME™ Activity 3: Exploring Combination Strategies in HR+/HER2– MBC: Where Do Oral SERDs Fit In?
Erica L. Mayer, MD, MPH; Jason Aboudi Mouabbi, MD
Oncology Town Hall: From Evidence to Action—Applying KRAS-Targeted Advances in Solid Tumors
Rajwanth Veluswamy, MD, MSCR; Alison Schram, MD; Brian M. Wolpin, MD, MPH
Project ECHO®: From Evidence to Action: Integrating New ADC Approaches to Optimize Treatment Sequencing in mTNBC
Tiffany A. Traina, MD, FASCO; Nour Abuhadra, MD; Joshua Z. Drago, MD, MS; Ya Haddy Sallah, MD, MPH
Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Kentucky
Lori A. Leslie, MD; Sushil Bhardwaj, MD, FACP
The ADC Revolution in Metastatic Breast Cancer: Redefining Treatment Selection and Sequencing
Seth A. Wander, MD, PhD; Reshma L. Mahtani, DO; Shanu Modi, MD; Joyce O’Shaughnessy, MD
Advancing Targeted Therapy in HR+/HER2– Metastatic Breast Cancer: Integrating Next-Generation Endocrine and PAM-Pathway Strategies Into Practice
Joyce O’Shaughnessy, MD; Sarat Chandarlapaty, MD, PhD; Mitchell Elliott, MD, FRCPC; Seth A. Wander, ...
OncoBytes Microlearning Pathways: New Directions in Triple-Negative Breast Cancer – Practice-Ready Updates and Expert Insights Into Recent Therapeutic Breakthroughs – Nursing (Part 1)
William J. Gradishar, MD, FASCO, FACP; Kamel Abou Hussein, MD
Introducing Novel Treatment Paradigms for Metastatic TNBC
Aditya Bardia, MD, MPH, FASCO; Alexis LeVee, MD
Key Considerations for Health Equity and Patient-Centered Care in TNBC
Aditya Bardia, MD, MPH, FASCO; Kathryn E. Post, PhD, ANP-BC
Current Approaches and Future Directions for Early-Stage TNBC
Nour Abuhadra, MD; Antonio Giordano, MD, PhD
From Trials to the Clinic ‒ Incorporating New Advances in Metastatic TNBC
William J. Gradishar, MD, FASCO, FACP; Kamel Abou Hussein, MD
Community Practice Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma
Geoffrey Ku, MD; Sunnie S. Kim, MD
“D” is for Diagnosis™: Seeking the Cause of Abdominal Pain
Brendan McGuire, MD, MS; Herbert Bonkovsky, MD
Advancing Access to High-Quality, Biomarker-Guided Care for All Patients With mNSCLC
Narjust Florez, MD, FASCO; Darren Luon, PharmD, BCOP; Dipesh Uprety, MD; Colton Zwart PharmD, BCOP
Optimizing NSCLC Readiness in the Era of TROP2-Targeted ADCs: Frontline Combinations, CNS Disease, and Toxicity Differentiation
Solange Peters, MD, PhD; Myung-Ju Ahn, MD, PhD; Benjamin P. Levy, MD; Stephanie McDonald, FNP-BC, AO...
Clinical Consultations: Comprehensive Management of Obesity as a Chronic Disease: New and Emerging Strategies
Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, FAAP, FAHA, FAMWA, FTOS; Robert Busch, MD
Expert Illustrations & Commentaries™: Outlining the Role of BTK inhibitors in Multiple Sclerosis
Stephen Krieger, MD, FAAN; Enrique Alvarez, MD, PhD
Cases and Conversations: Castleman Disease in Practice—Recognizing, Classifying, and Treating a Rare Disorder
Matthew Lunning, DO, FACP; Sudipto Mukherjee, MD, PhD, MPH; Frits van Rhee, MD, PhD, MRCP (UK), FRCP...
Project ECHO®: Extending the Impact of CAR T—Practical Approaches to Long-Term Care in the Community
Jesús G. Berdeja, MD; Nicholas Barkemeyer, PA-C, MPAS; Michael Byrne, DO, FACP
Project ECHO®: Navigating CRS and ICANS Related to CAR T-Cell Therapy: Prevention, Grading, and Management in Practice
Jesús G. Berdeja, MD; Michael Byrne, DO, FACP; Kyle T. Roberts, PA-C
Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Nevada
Krish Patel, MD; Matthew Ulrickson, MD
Project ECHO®: Building Bridges in CAR T Care: Collaborative Pathways to Improve Patient Access and Navigate Referrals
Jesús G. Berdeja, MD; Michael Byrne, DO, FACP; Katie Marcucci, DMSc, PA-C, CPAAPA; Xiaoxiao Zhang, A...
Oncology Town Hall: Insights Reshaping How We Treat MPNs From the 2026 Summer Oncology Meetings
John O. Mascarenhas, MD; Claire Harrison, MD, DM, FRCP, FRCPath; Raajit Rampal, MD, PhD
2027 International Symposium of Gastrointestinal Oncology (ISGIO®)
October 1-2, 2027
Clinical Crossroads™: The Importance of Considering Lambert-Eaton Myasthenic Syndrome (LEMS) in the Differential Diagnosis
Katherine Ruzhansky, MD, MS; Perry Shieh, MD, PhD, FAAN
Community Practice Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2– Metastatic Breast Cancer
Aditya Bardia, MD, MPH, FASCO; Kamel Abou Hussein, MD
Burst CME™ Part VI: What Does this all Mean for Patients with IgAN?
Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD
















































